Blood Protein Signature Predicts Lung Cancer Risk Before Diagnosis

Prothrombin Time, commonly known as PT, is a blood test that measures how long it takes for blood to clot. This test evaluates the function of specific proteins called clotting factors that are essential for normal blood coagulation. The PT test is particularly important for monitoring patients who take blood-thinning medications such as warfarin, as well as for diagnosing bleeding disorders and liver disease. The results are often reported as an INR (International Normalized Ratio), which standardizes the measurement across different laboratories.

The test works by measuring the time it takes for blood plasma to clot after adding a substance called thromboplastin. Normal PT values typically range from 11 to 13.5 seconds, though this can vary slightly between laboratories. When the PT is prolonged, it indicates that blood takes longer than normal to clot, which may suggest a deficiency in clotting factors, liver dysfunction, vitamin K deficiency, or the effect of anticoagulant medications. A shortened PT is less common but may occur in certain conditions involving increased clotting tendency.

Healthcare providers commonly order PT tests for several reasons. The most frequent use is monitoring patients on warfarin therapy to ensure the medication is working effectively without causing excessive bleeding risk. The test is also valuable in evaluating unexplained bleeding or bruising, assessing liver function since the liver produces most clotting factors, and screening patients before surgery to identify potential bleeding complications. Additionally, PT testing helps diagnose conditions such as disseminated intravascular coagulation (DIC) and vitamin K deficiency.

No special preparation is typically required for a PT test, though patients should inform their healthcare provider about all medications and supplements they are taking, as many substances can affect the results. The test requires a simple blood draw from a vein, usually in the arm. Results are generally available within a few hours to a day. For patients on warfarin, regular PT/INR monitoring is essential to maintain therapeutic levels and prevent complications from either excessive bleeding or inadequate anticoagulation.